Latest news
25 items- PRFrazier Life Sciences Adds Industry Veteran and Serial Dealmaker, Adam Simpson, to Company Creation TeamSimpson has helped build 11 companies that have been acquired or gone public, most recently serving as CEO of Icosavax Frazier Life Sciences (FLS), a longstanding investment firm investing in innovative biopharmaceuticals, today announced the addition of industry veteran Adam Simpson as Venture Partner in its Company Creation team. Over the last 25 years, Simpson has served as a co-founder, executive and/or board member of 11 life sciences companies that have either been acquired or gone public. His broad experience from these roles focuses on team building, advancing novel technologies through clinical proof-of-concept and leading significant fundraising, partnerships and acquisitions. H
- PRCHARM Therapeutics Announces Foundation of Scientific Advisory Board (SAB)PRESS RELEASE CHARM Therapeutics Announces Foundation of Scientific Advisory Board (SAB) LONDON – 19 March 2024 -- CHARM Therapeutics ("CHARM", "The Company"), a 3D deep-learning research company discovering and developing transformational medicines, today announces the foundation of its Scientific Advisory Board (SAB) to provide expert insight and guidance to the Company on the optimal application of 3D deep learning, protein design and prediction in real world medicine. The newly formed Board is comprised of world-leading experts whose skillsets span 3D deep learning and protein structure prediction, drug discovery and oncology. These individuals have a deep understanding of CHARM and
- SECSEC Form 15-12G filed by Icosavax Inc.15-12G - Icosavax, Inc. (0001786255) (Filer)
- 13D/GSEC Form SC 13D/A filed by Icosavax Inc. (Amendment)SC 13D/A - Icosavax, Inc. (0001786255) (Subject)
- 13D/GSEC Form SC 13D/A filed by Icosavax Inc. (Amendment)SC 13D/A - Icosavax, Inc. (0001786255) (Subject)
- SECSEC Form SC TO-T/A filed by Icosavax Inc. (Amendment)SC TO-T/A - Icosavax, Inc. (0001786255) (Subject)
- SECSEC Form EFFECT filed by Icosavax Inc.EFFECT - Icosavax, Inc. (0001786255) (Filer)
- INSIDERSEC Form 4 filed by Ra Capital Management, L.P.4 - Icosavax, Inc. (0001786255) (Issuer)
- INSIDERSimpson Adam K. closing all direct ownership in the company (SEC Form 4)4 - Icosavax, Inc. (0001786255) (Issuer)
- INSIDERSEC Form 4 filed by Khan Amin4 - Icosavax, Inc. (0001786255) (Issuer)
- INSIDERVeneman Ann M returned 2,834 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Icosavax, Inc. (0001786255) (Issuer)
- INSIDERCearley Cassia closing all direct ownership in the company (SEC Form 4)4 - Icosavax, Inc. (0001786255) (Issuer)
- INSIDERFields Heidi returned 2,917 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Icosavax, Inc. (0001786255) (Issuer)
- INSIDERWassil Jim returned 7,392 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Icosavax, Inc. (0001786255) (Issuer)
- INSIDERRusso Thomas Joseph closing all direct ownership in the company (SEC Form 4)4 - Icosavax, Inc. (0001786255) (Issuer)
- INSIDERShiver John W. returned 2,833 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Icosavax, Inc. (0001786255) (Issuer)
- INSIDERMcdade Mark closing all direct ownership in the company (SEC Form 4)4 - Icosavax, Inc. (0001786255) (Issuer)
- INSIDERKanesa-Thasan Niranjan closing all direct ownership in the company (SEC Form 4)4 - Icosavax, Inc. (0001786255) (Issuer)
- SECSEC Form 25-NSE filed by Icosavax Inc.25-NSE - Icosavax, Inc. (0001786255) (Subject)
- SECSEC Form S-8 POS filed by Icosavax Inc.S-8 POS - Icosavax, Inc. (0001786255) (Filer)
- SECSEC Form POS AM filed by Icosavax Inc.POS AM - Icosavax, Inc. (0001786255) (Filer)
- SECIcosavax Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits8-K - Icosavax, Inc. (0001786255) (Filer)
- SECSEC Form SC 14D9/A filed by Icosavax Inc. (Amendment)SC 14D9/A - Icosavax, Inc. (0001786255) (Subject)
- SECSEC Form SC TO-T/A filed by Icosavax Inc. (Amendment)SC TO-T/A - Icosavax, Inc. (0001786255) (Subject)
- 13D/GSEC Form SC 13G/A filed by Icosavax Inc. (Amendment)SC 13G/A - Icosavax, Inc. (0001786255) (Subject)
ICVX FAQ
6 questionsWhere does ICVX stock trade?
Icosavax Inc. (ICVX) is listed on NASDAQ.What sector and industry is ICVX in?
Icosavax Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did Icosavax Inc. go public?
Icosavax Inc. (ICVX) completed its IPO in 2021.What are analysts saying about ICVX?
Icosavax Inc. has had 8 recent analyst actions on file. The most recent action was from Guggenheim: Buy with a $2800.00 price target on 2023-11-17. Recent price targets range from $1000.00 to $4570.00.What companies are similar to ICVX?
Notable peers in the same industry include LLY (Eli Lilly and Company), AZN (AstraZeneca PLC), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare ICVX side-by-side with any of them on Quantisnow.How can I track ICVX on Quantisnow?
Quantisnow aggregates Icosavax Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ICVX to receive live email and push alerts on every new disclosure.